Related Experiment Videos
Platelet aggregation in feline cardiomyopathy
1Department of Medicine, School of Veterinary Medicine, Tufts University, North Grafton, MA 01536.
Insights
Cats with cardiomyopathy exhibit hyperaggregable platelets, responding to lower concentrations of adenosine diphosphate (ADP) than healthy cats. This suggests altered platelet function in feline heart disease.
Area of Science:
- Veterinary Medicine
- Hematology
- Cardiology
Background:
- Platelet aggregation plays a crucial role in hemostasis and thrombosis.
- Cardiomyopathy in cats can lead to complex physiological changes, potentially affecting blood components.
- Understanding platelet behavior is vital for diagnosing and managing cardiovascular diseases in felines.
Purpose of the Study:
- To investigate platelet aggregation response to adenosine diphosphate (ADP) in cats with cardiomyopathy.
- To determine the minimum ADP threshold concentration for irreversible platelet aggregation in healthy and affected cats.
- To explore potential correlations between platelet count and aggregation response in feline cardiomyopathy.
Main Methods:
- Evaluated platelet aggregation in 16 healthy cats and 10 cats with cardiomyopathy.
- Determined the minimum ADP concentration inducing irreversible (2nd-phase) aggregation for each cat.
- Measured platelet counts and analyzed aggregation curve parameters (lag phase, slope).
Main Results:
- Cats with cardiomyopathy showed significantly lower ADP thresholds for platelet aggregation (0.01–10 microM) compared to healthy cats (1–100 microM).
- 56% of healthy cats required 100 microM ADP for aggregation, while affected cats responded to much lower concentrations.
- No correlation was found between platelet count and the magnitude of the aggregation response.
Conclusions:
- Platelets from some cats with cardiomyopathy are hyperaggregable to ADP in vitro.
- Altered platelet function may be a contributing factor or consequence of cardiomyopathy in cats.
- Further research is warranted to elucidate the clinical implications of platelet hyperaggregability in feline heart disease.
Abstract:
Platelet aggregation in response to adenosine diphosphate (ADP) was evaluated in 16 healthy cats and in 10 cats with cardiomyopathy. The minimum threshold concentration of ADP required to induce irreversible (2nd-phase) aggregation was determined in each cat. The minimum ADP concentration needed for 2nd-phase aggregation in platelets from healthy cats ranged from 1 microM to 100 microM ADP, with 56% (9/16) requiring 100 microM ADP. Of the remaining seven normal cats, three had platelets responding irreversibly to 10 microM ADP, and four had platelets responding to 1 microM ADP. In cats with cardiomyopathy, the threshold concentrations ranged from 0.01 microM ADP to 10 microM ADP. Two cats had platelets responding irreversibly to 0.01 microM ADP, whereas another cat had a threshold response at 0.1 microM ADP. Platelets from the remaining seven cats with cardiomyopathy exhibited 2nd-phase aggregation in response to 1 microM ADP (five cats) or 10 microM ADP (two cats). Platelet counts ranged from 210,000/mm3 to 630,000/mm3 in healthy cats and from 218,000/mm3 to 624,000/mm3 in cats with cardiomyopathy. There was no apparent correlation between the platelet count and the magnitude of the threshold aggregation response, as measured by lag phase and slope of the aggregation curves. The results indicate that some cats with cardiomyopathy have platelets that are hyperaggregable to ADP in vitro.